Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations.
暂无分享,去创建一个
[1] A. Hofman,et al. Thiazide-associated hyponatremia: a population-based study. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[2] K. Swedberg,et al. Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. , 2013, Journal of cardiac failure.
[3] S. Silver,et al. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia. , 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[4] A. Amin,et al. Health Care Utilization, Costs, and Readmission Rates Associated With Hyponatremia , 2013, Hospital practice.
[5] M. Arıcı,et al. Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey , 2013, International Urology and Nephrology.
[6] A. Amin,et al. Healthcare resource burden associated with hyponatremia among patients hospitalized for heart failure in the US , 2013, Journal of medical economics.
[7] Eiji Higashihara,et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. , 2012, The New England journal of medicine.
[8] M. Pavesi,et al. Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema. , 2012, Journal of hepatology.
[9] A. Exadaktylos,et al. Characteristics, symptoms, and outcome of severe dysnatremias present on hospital admission. , 2012, The American journal of medicine.
[10] D. Bates,et al. Preoperative hyponatremia and perioperative complications. , 2012, Archives of internal medicine.
[11] Didar Singh. Risk of thiazide-induced hyponatremia in patients with hypertension. , 2012, The American journal of medicine.
[12] W. Abraham,et al. The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group study , 2012, European journal of heart failure.
[13] N. Madias,et al. The challenge of hyponatremia. , 2012, Journal of the American Society of Nephrology : JASN.
[14] M. Coffernils,et al. Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. , 2012, Clinical journal of the American Society of Nephrology : CJASN.
[15] S. Bratton,et al. Hyponatremia with intracranial malignant tumor resection in children. , 2012, Journal of neurosurgery. Pediatrics.
[16] C. Stefanadis,et al. Significance of Hyponatremia in Heart Failure , 2012 .
[17] L. Bankir,et al. Treatment of the Syndrome of Inappropriate Secretion of Antidiuretic Hormone with Urea in Critically Ill Patients , 2012, American Journal of Nephrology.
[18] C. Thompson,et al. Clinical review: Disorders of water homeostasis in neurosurgical patients. , 2012, The Journal of clinical endocrinology and metabolism.
[19] Jennie Z Ma,et al. Hyponatremia, Hypernatremia, and Mortality in Patients With Chronic Kidney Disease With and Without Congestive Heart Failure , 2012, Circulation.
[20] J. Dasta,et al. Evaluation of Costs Associated with Tolvaptan-Mediated Hospital Length of Stay Reduction Among US Patients with the Syndrome of Inappropriate Antidiuretic Hormone Secretion, Based on SALT-1 and SALT-2 Trials , 2012, Hospital practice.
[21] J. Dasta,et al. Evaluation of costs associated with tolvaptan-mediated length-of-stay reduction among heart failure patients with hyponatremia in the US, based on the EVEREST trial , 2012, Journal of medical economics.
[22] E. Girardin,et al. Inappropriate antidiuretic hormone secretion: long‐term successful urea treatment , 2012, Acta paediatrica.
[23] C. Orlandi,et al. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunction. , 2011, Journal of cardiac failure.
[24] S. Silver,et al. Diuretic-associated hyponatremia. , 2011, Seminars in nephrology.
[25] A. Maggioni,et al. Relation between serum sodium levels and prognosis in outpatients with chronic heart failure: neutral effect of treatment with beta-blockers and angiotensin-converting enzyme inhibitors data from the Italian network on congestive heart failure (IN-CHF database) , 2011, Journal of cardiovascular medicine.
[26] P. Hildebrandt,et al. Prevalence and prognostic significance of hyponatraemia in outpatients with chronic heart failure , 2011, European journal of heart failure.
[27] J. Tamargo,et al. Novel therapeutic targets for the treatment of heart failure , 2011, Nature Reviews Drug Discovery.
[28] M. Hoffman,et al. An Intervention Study of Oral Versus Intravenous Hypertonic Saline Administration in Ultramarathon Runners With Exercise-Associated Hyponatremia: A Preliminary Randomized Trial , 2011, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[29] T. Berl,et al. Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. , 2011, European journal of endocrinology.
[30] S. Nigwekar,et al. Mortality and serum sodium: do patients die from or with hyponatremia? , 2011, Clinical journal of the American Society of Nephrology : CJASN.
[31] A. Hofman,et al. Mild hyponatremia as a risk factor for fractures: The rotterdam study , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[32] M. Gheorghiade,et al. Tolvaptan for the treatment of heart failure: a review of the literature , 2011, Expert opinion on pharmacotherapy.
[33] T. Hato,et al. Diagnostic value of urine sodium concentration in hyponatremia due to syndrome of inappropriate antidiuretic hormone secretion versus hypovolemia. , 2010, Hawaii medical journal.
[34] G. Decaux,et al. Treatment of euvolemic hyponatremia in the intensive care unit by urea , 2010, Critical care.
[35] S. Silver,et al. Treating profound hyponatremia: a strategy for controlled correction. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[36] L. Behan,et al. Morbidity and mortality in patients with craniopharyngioma after surgery , 2010, Clinical endocrinology.
[37] 陶仲为,et al. Hyponatremia , 2010 .
[38] V. Arroyo,et al. Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration , 2010, Liver international : official journal of the International Association for the Study of the Liver.
[39] D. Gilbertson,et al. Renal effects of conivaptan, furosemide, and the combination in patients with chronic heart failure. , 2010, Journal of cardiac failure.
[40] J. Verbalis. Brain volume regulation in response to changes in osmolality , 2010, Neuroscience.
[41] S. Kimmel,et al. Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival , 2010, Circulation.
[42] M. Alberts,et al. Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU Patients , 2010, Neurocritical care.
[43] G. Kim,et al. Thiazide-Induced Hyponatremia , 2010, Electrolyte & blood pressure : E & BP.
[44] T. Berl,et al. Oral tolvaptan is safe and effective in chronic hyponatremia. , 2010, Journal of the American Society of Nephrology : JASN.
[45] T. Berl,et al. A patient with severe hyponatremia and hypokalemia: osmotic demyelination following potassium repletion. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[46] S. Störk,et al. Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. , 2010, The American journal of medicine.
[47] M. Moritz,et al. 100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy , 2010, Metabolic Brain Disease.
[48] J. Córdoba,et al. Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence , 2010, Metabolic Brain Disease.
[49] M. Gheorghiade,et al. Congestion as a therapeutic target in acute heart failure syndromes. , 2010, Progress in cardiovascular diseases.
[50] M. Panisset,et al. Central pontine and extrapontine myelinolysis: from epileptic and other manifestations to cognitive prognosis , 2010, Journal of Neurology.
[51] L. Price,et al. Impact of hospital-associated hyponatremia on selected outcomes. , 2010, Archives of internal medicine.
[52] M. Molloy,et al. Hyponatremia independent of osteoporosis is associated with fracture occurrence. , 2010, Clinical journal of the American Society of Nephrology : CJASN.
[53] R. Schrier,et al. Renal failure in cirrhosis. , 2009, The New England journal of medicine.
[54] W. Friedman,et al. HYPONATREMIA IN NEUROSURGICAL PATIENTS: CLINICAL GUIDELINES DEVELOPMENT , 2009, Neurosurgery.
[55] J. Brion,et al. Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. , 2009, Kidney international.
[56] J. Verbalis,et al. Hyponatremia-Induced Osteoporosis , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[57] R. Fisher,et al. Effect of hyponatraemia on outcomes following orthotopic liver transplantation , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[58] B. Gómez-Anson,et al. Hyponatremia Is a Risk Factor of Hepatic Encephalopathy in Patients With Cirrhosis: A Prospective Study With Time-Dependent Analysis , 2009, The American Journal of Gastroenterology.
[59] M. Devita,et al. Hyponatremia associated with large-bone fracture in elderly patients , 2009, International Urology and Nephrology.
[60] D. Mount. The brain in hyponatremia: both culprit and victim. , 2009, Seminars in nephrology.
[61] S. Fishbane,et al. More on renal salt wasting without cerebral disease: response to saline infusion. , 2009, Clinical journal of the American Society of Nephrology : CJASN.
[62] D. Annane,et al. Efficacy and Safety of Oral Conivaptan, a Vasopressin-Receptor Antagonist, Evaluated in a Randomized, Controlled Trial in Patients With Euvolemic or Hypervolemic Hyponatremia , 2009, The American journal of the medical sciences.
[63] P. Hamblin,et al. Patients Presenting with Severe Hypotonic Hyponatremia: Etiological Factors, Assessment, and Outcomes , 2009, Hospital practice.
[64] N. Morgenthaler,et al. Copeptin in the differential diagnosis of hyponatremia. , 2008, The Journal of clinical endocrinology and metabolism.
[65] T. Therneau,et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. , 2008, The New England journal of medicine.
[66] S. Störk,et al. Value of fractional uric acid excretion in differential diagnosis of hyponatremic patients on diuretics. , 2008, The Journal of clinical endocrinology and metabolism.
[67] M. Konstam,et al. Arginine Vasopressin Antagonists for the Treatment of Heart Failure and Hyponatremia , 2008, Circulation.
[68] C. Mélot,et al. Mild hyponatremia and risk of fracture in the ambulatory elderly. , 2008, QJM : monthly journal of the Association of Physicians.
[69] J. Verbalis,et al. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study , 2008, Clinical endocrinology.
[70] R. Geocadin,et al. Reversal of transtentorial herniation with hypertonic saline , 2008, Neurology.
[71] R. Kouides,et al. DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. , 2008, Clinical journal of the American Society of Nephrology : CJASN.
[72] R. Maughan,et al. Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007 , 2008, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[73] R. Kouides,et al. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection. , 2007, Clinical journal of the American Society of Nephrology : CJASN.
[74] David D. Shin,et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. , 2007, Archives of internal medicine.
[75] J. Verbalis,et al. Assessment of the Efficacy and Safety of Intravenous Conivaptan in Euvolemic and Hypervolemic Hyponatremia , 2007, American Journal of Nephrology.
[76] T. Berl,et al. The Syndrome of Inappropriate Antidiuresis , 2007 .
[77] G. Fonarow,et al. Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. , 2007, European heart journal.
[78] K. Swedberg,et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. , 2007, JAMA.
[79] J. Parma,et al. Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree. , 2007, Journal of the American Society of Nephrology : JASN.
[80] David D. Shin,et al. Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial , 2007, Acute cardiac care.
[81] P. Angeli,et al. Hyponatremia in cirrhosis: Results of a patient population survey , 2006, Hepatology.
[82] T. Berl,et al. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. , 2006, The New England journal of medicine.
[83] G. Robertson. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis. , 2006, The American journal of medicine.
[84] R. Schrier. Water and sodium retention in edematous disorders: role of vasopressin and aldosterone. , 2006, The American journal of medicine.
[85] G. Decaux. Is asymptomatic hyponatremia really asymptomatic? , 2006, The American journal of medicine.
[86] S. Silver,et al. Brain volume regulation in response to hypo-osmolality and its correction. , 2006, The American journal of medicine.
[87] N. Madias,et al. Incidence and prevalence of hyponatremia. , 2006, The American journal of medicine.
[88] K. Tuz,et al. Mechanisms of cell volume regulation in hypo-osmolality. , 2006, The American journal of medicine.
[89] R. Schrier. Body water homeostasis: clinical disorders of urinary dilution and concentration. , 2006, Journal of the American Society of Nephrology : JASN.
[90] S. Goldsmith. Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure. , 2006, Cleveland Clinic journal of medicine.
[91] J. Verbalis,et al. Cost of illness of hyponatremia in the United States , 2006, Cost effectiveness and resource allocation : C/E.
[92] K. Skagen,et al. Investigation and management of severe hyponatraemia in a hospital setting , 2006, Postgraduate Medical Journal.
[93] M. Gheorghiade,et al. Vasopressin antagonism in heart failure. , 2005, Journal of the American College of Cardiology.
[94] T. Noakes,et al. Consensus Statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005 , 2005, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[95] S. Gitelman,et al. Nephrogenic syndrome of inappropriate antidiuresis. , 2005, The New England journal of medicine.
[96] D. Wypij,et al. Hyponatremia among runners in the Boston Marathon. , 2005, The New England journal of medicine.
[97] J. Neher,et al. Clinical inquiries. Does furosemide decrease morbidity or mortality for patients with diastolic or systolic dysfunction? , 2005, The Journal of family practice.
[98] S. Hayasaka,et al. Protective effect of dexamethasone on osmotic-induced demyelination in rats , 2005, Experimental Neurology.
[99] W. Kremers,et al. Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[100] Thomas Petty,et al. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury* , 2005, Critical care medicine.
[101] G. Kim,et al. Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. , 2004, Journal of the American Society of Nephrology : JASN.
[102] B. C. Kwan,et al. Clinical studies of thiazide-induced hyponatremia. , 2004, Journal of the National Medical Association.
[103] D. Stoddard. Fluid replacement during marathon running. , 2004, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.
[104] Christopher M O'Connor,et al. Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. , 2004, JAMA.
[105] M. Moritz,et al. The pathophysiology and treatment of hyponatraemic encephalopathy: an update. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[106] T. Wong,et al. Risk factors for thiazide-induced hyponatraemia. , 2003, QJM : monthly journal of the Association of Physicians.
[107] R. Hawkins. Age and gender as risk factors for hyponatremia and hypernatremia. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[108] A. Turchin,et al. Clinical problem-solving. Mind the gap. , 2003, The New England journal of medicine.
[109] W. Oelkers,et al. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. , 2003, European journal of endocrinology.
[110] C. Nzerue,et al. Predictors of outcome in hospitalized patients with severe hyponatremia. , 2003, Journal of the National Medical Association.
[111] R. Abouqal,et al. Incidence, étiologies et facteurs pronostiques de l'hyponatrémie en réanimation , 2003 .
[112] A. Tuttolomondo,et al. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects. , 2003, American heart journal.
[113] O. Jolobe. Diuretic-induced hyponatraemia in elderly hypertensive women , 2003, Journal of Human Hypertension.
[114] A. Miccio. Clinical Problem Solving , 2002 .
[115] S. Silver,et al. Rapid (24-hour) reaccumulation of brain organic osmolytes (particularly myo-inositol) in azotemic rats after correction of chronic hyponatremia. , 2002, Journal of the American Society of Nephrology : JASN.
[116] Toshihito Suzuki,et al. Risperidone failed to improve polydipsia‐hyponatremia of the schizophrenic patients , 2002, Psychiatry and clinical neurosciences.
[117] R. Schrier. Diseases of the Kidney and Urinary Tract , 2001 .
[118] T. Noakes,et al. Peak rates of diuresis in healthy humans during oral fluid overload. , 2001, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[119] K Sauer,et al. [Clinical problem solving]. , 2001, Praxis.
[120] J. Verbalis,et al. Blood–Brain Barrier Disruption and Complement Activation in the Brain Following Rapid Correction of Chronic Hyponatremia , 2000, Experimental Neurology.
[121] J. Varon,et al. Hyponatremia, Cerebral Edema, and Noncardiogenic Pulmonary Edema in Marathon Runners , 2000, Annals of Internal Medicine.
[122] B. Brenner. Brenner and Rector's The Kidney , 2000 .
[123] A. Arieff,et al. Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. , 1999, JAMA.
[124] T. Noakes,et al. Hyponatremia in ultradistance triathletes. , 1999, Medicine and science in sports and exercise.
[125] R. Abbott,et al. Hyponatremia: evaluating the correction factor for hyperglycemia. , 1999, The American journal of medicine.
[126] M. Goldman,et al. Clozapine restores water balance in schizophrenic patients with polydipsia-hyponatremia syndrome. , 1999, The Journal of neuropsychiatry and clinical neurosciences.
[127] T. Berl,et al. Hyponatremia in cirrhosis: From pathogenesis to treatment , 1998, Hepatology.
[128] R. Schrier,et al. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. , 1998, The New England journal of medicine.
[129] T. Berl,et al. "Beer potomania" in non-beer drinkers: effect of low dietary solute intake. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[130] G. Klintmalm,et al. Liver transplantation in hyponatremic patients with emphasis on central pontine myelinolysis. , 1998, Clinical transplantation.
[131] W. Abraham,et al. Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. , 1998, Journal of cardiac failure.
[132] M. Scanlon,et al. Hyponatraemia, hypothyroidism, and role of arginine-vasopressin , 1997, The Lancet.
[133] R. Pirskanen,et al. Fatal hyponatraemic brain oedema due to common gastroenteritis with accidental water intoxication , 1997, Intensive Care Medicine.
[134] V. Rajshekhar,et al. Validation study of a central venous pressure-based protocol for the management of neurosurgical patients with hyponatremia and natriuresis. , 1997, Neurosurgery.
[135] O. Périer,et al. Brain Myelinolysis Following Hypernatremia in Rats , 1996, Journal of neuropathology and experimental neurology.
[136] S. Ellis,et al. Severe hyponatraemia: complications and treatment. , 1995, QJM : monthly journal of the Association of Physicians.
[137] L. Rubenstein,et al. Hyponatremia in a Nursing Home Population , 1995, Journal of the American Geriatrics Society.
[138] K. Strange,et al. Regulation of cell volume in health and disease. , 1995, The New England journal of medicine.
[139] Y. Lien. Role of organic osmolytes in myelinolysis. A topographic study in rats after rapid correction of hyponatremia. , 1995, The Journal of clinical investigation.
[140] A. Arieff,et al. Clinical Investigations in Critical CarePulmonary Complications of Hyponatremic Encephalopathy: Noncardiogenic Pulmonary Edema and Hypercapnic Respiratory Failure , 1995 .
[141] B. Garo,et al. High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients. , 1994, The Journal of clinical psychiatry.
[142] G. Simpson,et al. Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature , 1994, Biological Psychiatry.
[143] S. Silver,et al. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective. , 1994, Journal of the American Society of Nephrology : JASN.
[144] Y. Yamamura,et al. Potent aquaretic agent. A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. , 1993, The Journal of clinical investigation.
[145] R. Laureno,et al. Pontine and Extrapontine Myelinolysis: A Neurologic Disorder following Rapid Correction of Hyponatremia , 1993, Medicine.
[146] W. Jiménez,et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. , 1993, Gastroenterology.
[147] Y. Friedlander,et al. Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. , 1993, Chest.
[148] R. Hales,et al. J Neuropsychiatry Clin Neurosci , 1992 .
[149] T. Noakes,et al. Evaluation of renal function and fluid homeostasis during recovery from exercise-induced hyponatremia. , 1991, Journal of applied physiology.
[150] M. Devita,et al. Incidence and etiology of hyponatremia in an intensive care unit. , 1990, Clinical nephrology.
[151] R. Schrier. Body fluid volume regulation in health and disease: a unifying hypothesis. , 1990, Annals of internal medicine.
[152] D. Peterson,et al. Long-term neurologic outcome in psychogenic water drinkers with severe symptomatic hyponatremia: the effect of rapid correction. , 1990, The American journal of medicine.
[153] A. Meinders,et al. Management of severe hyponatremia: rapid or slow correction? , 1990, The American journal of medicine.
[154] E. Wijdicks,et al. Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage , 1990, Annals of neurology.
[155] S. Elias,et al. Central pontine myelinolysis and pontine lesions after rapid correction of hyponatremia: A prospective magnetic resonance imaging study , 1990, Annals of neurology.
[156] E. Wijdicks,et al. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. , 1989, Stroke.
[157] W. Oelkers,et al. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. , 1989, The New England journal of medicine.
[158] S. Davis,et al. Effect of blood glucose concentration on osmoregulation in diabetes mellitus. , 1989, The American journal of physiology.
[159] L. Weisberg. Pseudohyponatremia: a reappraisal. , 1989, The American journal of medicine.
[160] R. Schrier. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1) , 1988, The New England journal of medicine.
[161] G. Yank,et al. Diurnal variation in water homeostasis among schizophrenic patients subject to water intoxication , 1988, Schizophrenia Research.
[162] Vicente Arroyo,et al. Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.
[163] D. Luchins,et al. Mechanisms of altered water metabolism in psychotic patients with polydipsia and hyponatremia. , 1988, The New England journal of medicine.
[164] A. Arieff,et al. Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. , 1987, The New England journal of medicine.
[165] R. Anderson,et al. Clinical assessment of extracellular fluid volume in hyponatremia. , 1987, The American journal of medicine.
[166] R H Sterns,et al. Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases. , 1987, Annals of internal medicine.
[167] J. Hainsworth,et al. The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[168] J. Riggs,et al. Osmotic demyelination syndrome following correction of hyponatremia. , 1986, The New England journal of medicine.
[169] A. Arieff. Hyponatremia, convulsions, respiratory arrest, and permanent brain damage after elective surgery in healthy women. , 1986, The New England journal of medicine.
[170] J. Cohn,et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. , 1985, Annals of internal medicine.
[171] I. Zucker,et al. Impaired atrial receptor modulation or renal nerve activity in dogs with chronic volume overload1 , 1985 .
[172] A. Arieff,et al. Changing concep in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis , 1985 .
[173] R. Schrier. Treatment of hyponatremia. , 1985, The New England journal of medicine.
[174] R. Anderson,et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenetic role of vasopressin. , 1985, Annals of internal medicine.
[175] J. van Gijn,et al. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: Is fluid restriction harmful? , 1985, Annals of neurology.
[176] G. Robertson,et al. Abnormalities of thirst regulation. , 1984, Kidney international.
[177] R. Schrier,et al. Central nervous system mediators of vasopressin release. , 1983, Physiological reviews.
[178] R. Schrier,et al. Effect of arginine vasopressin antagonist on renal water excretion in glucocorticoid and mineralocorticoid deficient rats. , 1982, Kidney international.
[179] R. Schrier,et al. Role of vasopressin in abnormal water excretion in cirrhotic patients. , 1982, Annals of internal medicine.
[180] G. Robertson,et al. Neurogenic disorders of osmoregulation. , 1982, The American journal of medicine.
[181] T. Berl,et al. Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. , 1981, The New England journal of medicine.
[182] H. Lebovitz,et al. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. , 1980, The New England journal of medicine.
[183] R. Schrier,et al. Plasma demeclocycline levels and nephrotoxicity. Correlation in hyponatremic cirrhotic patients. , 1980, JAMA.
[184] L. Beck. Hypouricemia in the Syndrome of Inappropriate Secretion of Antidiuretic Hormone , 1979 .
[185] J. P. Gilmore,et al. Renal effects of left atrial distension in dogs with chronic congestive heart failure. , 1979, The American journal of physiology.
[186] J. Birge,et al. Demeclocycline treatment in the syndrome of inappropriate antidiuretic hormone secretion. , 1975, Annals of internal medicine.
[187] B. Brenner,et al. Effects of Norepinephrine and Angiotensin II on the Determinants of Glomerular Ultrafiltration and Proximal Tubule Fluid Reabsorption in the Rat , 1975, Circulation research.
[188] M. F. Michelis,et al. Reset of osmoreceptors in association with normovolemic hyponatremia , 1974, The American journal of the medical sciences.
[189] D. Wilson,et al. Effects of demethylchlortetracycline on cellular action of antidiuretic hormone in vitro. , 1974, Kidney international.
[190] T. Berl,et al. Mechanism of stimulation of vasopressin release during beta adrenergic stimulation with isoproterenol. , 1974, The Journal of clinical investigation.
[191] B. Prince,et al. Compulsive water drinking. , 1973, The American journal of psychiatry.
[192] C. Kleeman,et al. Diuretic-induced hyponatremia. , 1971, Annals of internal medicine.
[193] H. Bleiberg,et al. Coma due to water intoxication in beer drinkers. , 1971, Lancet.
[194] D. Mintz,et al. Impaired water excretion in myxedema. , 1971, The American journal of medicine.
[195] A. Chinitz,et al. The association of primary hypothyroidism and inappropriate secretion of antidiuretic hormone. , 1965, Archives of internal medicine.
[196] W. Schwartz,et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. , 1957, The American journal of medicine.
[197] H. Olivecrona,et al. Hypophysectomy in man: effect on water excretion during the first two postoperative months. , 1955, The Journal of clinical endocrinology and metabolism.
[198] F. C. Helwig,et al. WATER INTOXICATION: MORIBUND PATIENT CURED BY ADMINISTRATION OF HYPERTONIC SALT SOLUTION , 1938 .
[199] T. Sane. [Disorders of water balance]. , 2015, Duodecim; laaketieteellinen aikakauskirja.
[200] B. Okopień,et al. [Syndrome of inappropriate secretion of antidiuretic hormone]. , 2014, Przeglad lekarski.
[201] A. Amin,et al. Hyponatremia-Associated Healthcare Burden Among US Patients Hospitalized for Cirrhosis , 2012, Advances in Therapy.
[202] C. O'connor,et al. Hyponatremia and long-term outcomes in chronic heart failure--an observational study from the Duke Databank for Cardiovascular Diseases. , 2012, Journal of cardiac failure.
[203] E. Eugster. Presentation of Primary Adrenal Insufficiency in Childhood , 2012 .
[204] S. Waikar,et al. Mortality associated with low serum sodium concentration in maintenance hemodialysis. , 2011, The American journal of medicine.
[205] P. Gross. Treatment of hyponatremia. , 2008, Internal medicine.
[206] John W. Winkelman. The American Journal of Medicine , 2007 .
[207] T. Berl,et al. Clinical practice. The syndrome of inappropriate antidiuresis. , 2007, The New England journal of medicine.
[208] S. Gitelman,et al. Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children. , 2006, The Journal of pediatrics.
[209] M. Manto,et al. Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. , 2006, The American journal of medicine.
[210] A. Zeggwagh,et al. [Incidence, causes and prognostic factors of hyponatremia in intensive care]. , 2003, La Revue de medecine interne.
[211] M. Thibonnier,et al. Molecular pharmacology of human vasopressin receptors. , 1998, Advances in experimental medicine and biology.
[212] M. Knepper. Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. , 1997, The American journal of physiology.
[213] H. Halkin,et al. Thiazide-induced hyponatremia. Reproducibility by single dose rechallenge and an analysis of pathogenesis. , 1989, Annals of internal medicine.
[214] T. Maudelonde,et al. The Lancet: saturday 11 November 1989 , 1989 .
[215] J. Verbalis,et al. Effect of protein intake and urea on sodium excretion during inappropriate antidiuresis in rats. , 1988, Metabolism: clinical and experimental.
[216] R. Schrier. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) , 1988, The New England journal of medicine.
[217] I. Zucker,et al. Imparied atrial receptor modulation or renal nerve activity in dogs with chronic volume overload. , 1985, Cardiovascular research.
[218] A. Arieff,et al. Changing concepts in treatment of severe symptomatic hyponatremia. Rapid correction and possible relation to central pontine myelinolysis. , 1985, The American journal of medicine.
[219] G. Robertson,et al. Vasopressin function in the syndrome of inappropriate antidiuresis. , 1980, Annual review of medicine.